Depression
Authors: Tonya Fancher
Journal: Annals of Internal Medicine (2007)

In the Clinic1 May 2007DepressionChristine Laine, MD, MPH, David R. Goldman, MD, Tonya Fancher, MD, and Richard Kravitz, MDChristine Laine, MD, MPHSearch for more papers by this author, David R. Goldman, MDSearch for more papers by this author, Tonya Fancher, MDSearch for more papers by this author, and Richard Kravitz, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-146-9-200705010-01005 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Editor's Note: This issue of In the Clinic has been updated.Depression is common in primary care, affecting 5% to 10% of patients in this setting (1). Untreated depression may be a barrier to effective treatment of common co-occurring illnesses (e.g., diabetes and cardiovascular disease) (2). The disability associated with depression is similar to that of other chronic medical conditions (3). Depression is currently the fourth leading contributor to the global burden of disease (as measured using disability-adjusted life-years) and will move into second place by 2020 (4). Effective treatment of depression reduces symptoms and improves quality of life (5). ...References1. Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136:765-76. [PMID: 12020146] Google Scholar2. Katon WJ, Schoenbaum M, Fan MY, et al. Cost-effectiveness of improving primary care treatment of late-life depression. Arch Gen Psychiatry. 2005;62:1313-20. [PMID: 16330719] Google Scholar3. Hays RD, Wells KB, Sherbourne CD, Rogers W, Spritzer K. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry. 1995;52:11-9. [PMID: 7811158] Google Scholar4. Remick RA. Diagnosis and management of depression in primary care: a clinical update and review. CMAJ. 2002;167:1253-60. [PMID: 12451082] Google Scholar5. Heiligenstein JH, Ware JE Jr., Beusterien KM, et al. Acute effects of fluoxetine versus placebo on functional health and well-being in late-life depression. Int Psychogeriatr. 1995;7 Suppl:125-37. [PMID: 8580388] Google Scholar6. McDonald WM, Richard IH, DeLong MR. Prevalence, etiology, and treatment of depression in Parkinson’s disease. Biol Psychiatry. 2003;54:363-75. [PMID: 12893111] Google Scholar7. Beck CT. Predictors of postpartum depression: an update. Nurs Res. 2001;50:275-85. [PMID: 11570712] Google Scholar8. Person C, Tracy M, Galea S. Risk factors for depression after a disaster. J Nerv Ment Dis. 2006;194:659-66. [PMID: 16971817] Google Scholar9. Kendler KS, Gardner CO, Prescott CA. Clinical characteristics of major depression that predict risk of depression in relatives. Arch Gen Psychiatry. 1999;56:322-7. [PMID: 10197826] Google Scholar10. Runeson B, Asberg M. Family history of suicide among suicide victims. Am J Psychiatry. 2003;160:1525-6. [PMID: 12900320] Google Scholar11. Terre L, Poston WS, Foreyt J, St Jeor ST. Do somatic complaints predict subsequent symptoms of depression? Psychother Psychosom. 2003;72:261-7. [PMID: 12920330] Google Scholar12. Mulrow CD, Williams JW Jr., Gerety MB, et al. Case-finding instruments for depression in primary care settings. Ann Intern Med. 1995;122:913-21. [PMID: 7755226] Google Scholar13. Beck AT, Steer RA, Brown GK. BDI-II, Beck Depression Inventory: Manual. 2nd ed. Boston: Harcourt Brace; 1996. Google Scholar14. Georgiopoulos AM, Bryan TL, Yawn BP, et al. Population-based screening for postpartum depression. Obstet Gynecol. 1999;93:653-7. [PMID: 10912961] Google Scholar15. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell Scale for Depression in Dementia. Biol Psychiatry. 1988;23:271-84. [PMID: 3337862] Google Scholar16. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62. [PMID: 14399272] Google Scholar17. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed. Washington, DC: American Psychiatric Association; 1994. Google Scholar18. Brody DS, Hahn SR, Spitzer RL, et al. Identifying patients with depression in the primary care setting: a more efficient method. Arch Intern Med. 1998;158:2469-75. [PMID: 9855385] Google Scholar19. Thase ME, Greenhouse JB, Frank E, et al. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry. 1997;54:1009-15. [PMID: 9366657] Google Scholar20. Löwe B, Unützer J, Callahan CM, Perkins AJ, Kroenke K. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care. 2004;42:1194-201. [PMID: 15550799] Google Scholar21. Depression Guideline Panel. Depression in Primary Care: Treatment for Major Depression, Volume 2. Clinical Practice Guideline No. 5. Rockville, MD: US Department of Health and Human Services Agency for Health Care Policy and Research; 1993. Google Scholar22. Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg. 2005;24:92-102. [PMID: 16092797] Google Scholar23. Frasure-Smith N. The Montreal Heart Attack Readjustment Trial. J Cardiopulm Rehabil. 1995;15:103-6. [PMID: 8542512] Google Scholar24. House A, Dennis M, Mogridge L, et al. Mood disorders in the year after first stroke. Br J Psychiatry. 1991;158:83-92. [PMID: 2015456] Google Scholar25. Popkin MK, Callies AL, Lentz RD, Colon EA, Sutherland DE. Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing type I diabetes mellitus. Arch Gen Psychiatry. 1988;45:64-8. [PMID: 3257379] Google Scholar26. Schleifer SJ, Macari-Hinson MM, Coyle DA, et al. The nature and course of depression following myocardial infarction. Arch Intern Med. 1989;149:1785-9. [PMID: 2788396] Google Scholar27. Depression Guideline Panel. Depression in Primary Care: Detection and Diagnosis, Volume 1. Clinical Practice Guideline No. 5. Rockville, MD: US Department of Health and Human Services Agency for Health Care Policy and Research; 1993. Google Scholar28. Geringer ES, Perlmuter LC, Stern TA, Nathan DM. Depression and diabetic neuropathy: a complex relationship. J Geriatr Psychiatry Neurol. 1988;1:11-5. [PMID: 3252874] Google Scholar29. Moscicki EK. Identification of suicide risk factors using epidemiologic studies. Psychiatr Clin North Am. 1997;20:499-517. [PMID: 9323310] Google Scholar30. Brody DS, Thompson TL 2nd, Larson DB, et al. Recognizing and managing depression in primary care. Gen Hosp Psychiatry. 1995;17:93-107. [PMID: 7789790] Google Scholar31. Mann JJ, Apter A, Bertolote J, et al. Suicide prevention strategies: a systematic review. JAMA. 2005;294:2064-74. [PMID: 16249421] Google Scholar32. Vaiva G, Vaiva G, Ducrocq F, et al. Effect of telephone contact on further suicide attempts in patients discharged from an emergency department: randomised controlled study. BMJ. 2006;332:1241-5. [PMID: 16735333] Google Scholar33. Stanford EJ, Goetz RR, Bloom JD. The No Harm Contract in the emergency assessment of suicidal risk. J Clin Psychiatry. 1994;55:344-8. [PMID: 8071303] Google Scholar34. Kirmayer LJ, Groleau D, Guzder J, Blake C, Jarvis E. Cultural consultation: a model of mental health service for multicultural societies. Can J Psychiatry. 2003;48:145-53. [PMID: 12728738] Google Scholar35. Hofmann DP, Dubovsky SL. Depression and suicide assessment. Emerg Med Clin North Am. 1991;9:107-21. [PMID: 2001661] Google Scholar36. Goldberg JF, Ernst CL. Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. J Clin Psychiatry. 2002;63:985-91. [PMID: 12444811] Google Scholar37. Burns DD. Feeling Good-The New Mood Therapy Revised and Updated. New York: Avon; 1999. Google Scholar38. Anderson L, Lewis G, Araya R, et al. Self-help books for depression: how can practitioners and patients make the right choice? Br J Gen Pract. 2005;55:387-92. [PMID: 15904559] Google Scholar39. Fava GA, Rafanelli C, Grandi S, Canestrari R, Morphy MA. Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry. 1998;155:1443-5. [PMID: 9766780] Google Scholar40. Thase ME, Trivedi MH, Rush AJ. MAOIs in the contemporary treatment of depression. Neuropsychopharmacology. 1995;12:185-219. [PMID: 7612154] Google Scholar41. Kroenke K, West SL, Swindle R, et al. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA. 2001;286:2947-55. [PMID: 11743835] Google Scholar42. Williams JW Jr., Mulrow CD, Chiquette E, et al. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med. 2000;132:743-56. [PMID: 10787370] Google Scholar43. Lin EH, Von Korff M, Katon W, et al. The role of the primary care physician in patients’ adherence to antidepressant therapy. Med Care. 1995;33:67-74. [PMID: 7823648] Google Scholar44. Wells KB, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA. 2000;283:212-20. [PMID: 10634337] Google Scholar45. Dubicka B, Hadley S, Roberts C. Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis. Br J Psychiatry. 2006;189:393-8. [PMID: 17077427] Google Scholar46. Grunebaum MF, Ellis SP, Li S, Oquendo MA, Mann JJ. Antidepressants and suicide risk in the United States, 1985-1999. J Clin Psychiatry. 2004;65:1456-62. [PMID: 15554756] Google Scholar47. Pies RW, Rogers DP. Handbook of Essential Psychopharmacology. 2nd ed. Arlington, VA: American Psychiatric Publishing; 2005. Google Scholar48. Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354:1243-52. [PMID: 16554526] Google Scholar49. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am. 1996;19:179-200. [PMID: 8827185] Google Scholar50. Spier SA. Use of bupropion with SRIs and venlafaxine. Depress Anxiety. 1998;7:73-5. [PMID: 9614595] Google Scholar51. Carpenter LL, Jocic Z, Hall JM, Rasmussen SA, Price LH. Mirtazapine augmentation in the treatment of refractory depression. J Clin Psychiatry. 1999;60:45-9. [PMID: 10074878] Google Scholar52. Nelson JC. Augmentation strategies in depression 2000. J Clin Psychiatry. 2000;61 Suppl 2:13-9. [PMID: 10714619] Google Scholar53. Nurnberg HG, Hensley PL. Selective phosphodiesterase type-5 inhibitor treatment of serotonergic reuptake inhibitor antidepressant-associated sexual dysfunction: a review of diagnosis, treatment, and relevance. CNS Spectr. 2003;8:194-202. [PMID: 12595814] Google Scholar54. Linde K, Mulrow CD, Berner M, Egger M. St John’s wort for depression. Cochrane Database Syst Rev. 2005:CD000448. [PMID: 15846605] Google Scholar55. Obach RS. Inhibition of human cytochrome P450 enzymes by constituents of St. John’s Wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther. 2000;294:88-95. [PMID: 10871299] Google Scholar56. de Maat MM, Hoetelmans RM, Math t RA, et al. Drug interaction between St John’s wort and nevirapine. AIDS. 2001;15:420-1. [PMID: 11273226] Google Scholar57. Ondrizek RR, Chan PJ, Patton WC, King A. Inhibition of human sperm motility by specific herbs used in alternative medicine. J Assist Reprod Genet. 1999;16:87-91. [PMID: 10079411] Google Scholar58. FDA Public Health Advisory: Treatment Challenges of Depression in Pregnancy. Rockville, MD: U.S. Food and Drug Administration; 2006. Google Scholar59. Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006;354:579-87. [PMID: 16467545] Google Scholar60. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295:499-507. [PMID: 16449615] Google Scholar61. Miller LJ. Psychiatric Medication During Pregnancy: Understanding and Minizing Risks. Psychiatric Annals. 1994;24:69-75. Google Scholar62. Delgado PL. Approaches to the enhancement of patient adherence to antidepressant medication treatment. J Clin Psychiatry. 2000;61 Suppl 2:6-9. [PMID: 10714617] Google Scholar Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byQuestionable Agreement: The Experience of Depression and DSM-5 Major Depressive Disorder CriteriaAntilipidemic adherence post-coronary artery disease diagnosis among those with and without an ICD-9 diagnosis of depressionAssociation of vitamin D levels with incident depression among a general cardiovascular populationDepression After Coronary Artery Disease Is Associated With Heart Failure 1 May 2007Volume 146, Issue 9Page: ITC5-1KeywordsAntidepressant drug therapyDiagnostic and Statistical Manual of Mental Disorders fourth editionDrug therapyEmotionsFood and Drug AdministrationHospitalizationsPregnancySelective serotonin reuptake inhibitorsSubstance abuseSuicide ePublished: 1 May 2007 Issue Published: 1 May 2007 Copyright & PermissionsCopyright © 2007 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...